Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Profound Medical (PROF) Accounts Payables (2023 - 2025)

Profound Medical has reported Accounts Payables over the past 3 years, most recently at $1.6 million for Q4 2025.

  • Quarterly results put Accounts Payables at $1.6 million for Q4 2025, up 18.68% from a year ago — trailing twelve months through Dec 2025 was $1.6 million (up 18.68% YoY), and the annual figure for FY2025 was $1.6 million, up 18.68%.
  • Accounts Payables for Q4 2025 was $1.6 million at Profound Medical, up from $717000.0 in the prior quarter.
  • Over the last five years, Accounts Payables for PROF hit a ceiling of $1.6 million in Q4 2025 and a floor of $717000.0 in Q3 2025.
  • Median Accounts Payables over the past 3 years was $998500.0 (2025), compared with a mean of $1.1 million.
  • Biggest five-year swings in Accounts Payables: surged 52.25% in 2024 and later rose 18.68% in 2025.
  • Profound Medical's Accounts Payables stood at $865000.0 in 2023, then surged by 52.25% to $1.3 million in 2024, then rose by 18.68% to $1.6 million in 2025.
  • The last three reported values for Accounts Payables were $1.6 million (Q4 2025), $717000.0 (Q3 2025), and $949000.0 (Q2 2025) per Business Quant data.